PLXS Rule 144 Notice — 1,576 Performance Shares Scheduled for Sale
Rhea-AI Filing Summary
Plexus Corp (PLXS) Form 144 notice shows a proposed sale of 1,576 common shares through Morgan Stanley Smith Barney on 08/25/2025 with an aggregate market value of $217,133.40. The shares were acquired as performance shares from the issuer on 02/13/2024. The filing also reports a prior sale by Angelo M. Ninivaggi of 2,058 common shares on 05/27/2025 for gross proceeds of $272,112.88. The issuer's total shares outstanding are reported as 26,986,726, and the proposed sale lists NASDAQ as the exchange. The filer certifies no undisclosed material adverse information is known.
Positive
- Full Rule 144 compliance details provided: broker, number of shares, acquisition date, and prior sales are disclosed
- Transparency on recent activity: prior sale of 2,058 shares with gross proceeds ($272,112.88) is reported
Negative
- None.
Insights
TL;DR: Routine Rule 144 filing disclosing a small planned sale of performance shares and a recent related sale.
The notice provides clear transactional detail: acquisition date of the 1,576 shares is 02/13/2024 (performance shares), with the planned brokered sale slated for 08/25/2025 on NASDAQ. The filing quantifies shares outstanding at 26,986,726, allowing investors to gauge scale: the proposed sale is approximately 0.0058% of outstanding shares, indicating immaterial market impact at face value. The prior sale on 05/27/2025 (2,058 shares, $272,112.88) is disclosed, supporting transparency about recent insider-related dispositions. No financial results, insider relationship, or plan adoption details are provided in the form.
TL;DR: Disclosure aligns with Rule 144 requirements; document affirms absence of undisclosed material information by the seller.
The filing meets procedural expectations by naming the broker, listing acquisition type (performance shares), and stating prior sales during the past three months. The signature representation that the seller lacks undisclosed material adverse information is present, which is standard language in Form 144 submissions. The filing does not specify the seller's formal relationship to the issuer, so governance implications regarding dilution or insider timing cannot be further assessed from this document alone.
FAQ
When is the proposed sale scheduled and through which broker?
What recent sales by the same person are reported in the Form 144?